Skip to main content
Clinical Trials/NCT04446897
NCT04446897CompletedPhase 1

Treatment of Chronic Medium-severe Periodontitis With Mesenchymal Stem Cells Predifferentiated in Osteogenic Direction Immobilised on a Biodegradable Carrier

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus2 sites in 1 country10 target enrollmentStarted: August 3, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
10
Locations
2
Primary Endpoint
number of patients cured

Study Overview

Brief Summary

Treatment of chronic medium-severe periodontitis with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Detailed Description

The bone defect will be filled with a porous membrane based on bone collagen measuring 5x5 mm or more with mesenchymal stem cells and mesenchymal stem cells predifferentiated in osteogenic direction

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
70 Years to 70 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • chronic medium-severe periodontitis

Exclusion Criteria

  • pregnancy
  • breast-feeding
  • acute and chronic infectious diseases: HIV, viral hepatitis, tuberculosis
  • mental disorders

Arms & Interventions

mesenchymal stem cells

Experimental

standard treatment according to clinical protocols plus mesenchymal stem cells

Intervention: mesenchymal stem cells (Biological)

Outcomes

Primary Outcomes

number of patients cured

Time Frame: 1 month

number of patients cured

Secondary Outcomes

No secondary outcomes reported

Investigators

Study Sites (2)

Loading locations...

Similar Trials